Skip to main content
Figure 2 | BMC Nuclear Medicine

Figure 2

From: Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses

Figure 2

Hematologic function. Hematologic function: Red blood cells (A), white blood cells (B), hematocrit (C) levels sampled before FLT injection (Pre-FLT), up to 5 hours post-FLT (Immediate <5 h), between 5 and 24 hours (5–24 h), between day 1 and 7 (1–7 d) and later than one week (>1 wk) after FLT injection. Lines link all values for an individual patient over time. On Figures A & C the means +/- standard deviations for red blood cells (A) and hematocrit (C) are plotted over time. Dotted horizontal lines illustrate the upper and lower normal limits (reference range) for each test.

Back to article page

BMC Medical Physics

ISSN: 1756-6649